Back to Market Feed

DABIGATRAN ETEXILATE 150 MG CP

Dabigatran etexilate
$0.8705per EA

Strength

150 mg/1

NDC

43598064160

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208048

On Market Since

2/28/2025

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price History

1W

0.0%

1M

-1.4%

3M

-3.4%

6M

-20.1%

1Y

-45.0%

3Y

N/A

5Y

N/A

All

-47.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

DABIGATRAN ETEXILATE 75 MG CAP
Generic
00378026591•Mylan Pharmaceuticals Inc.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
00904725304•Major Pharmaceuticals
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
00904725368•Major Pharmaceuticals
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
31722062132•Camber Pharmaceuticals Inc.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
31722062160•Camber Pharmaceuticals Inc.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
59651097360•Aurobindo Pharma Limited
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
60505434706•Apotex Corp.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
62332063406•Alembic Pharmaceuticals Inc.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
62332063460•Alembic Pharmaceuticals Inc.
$0.8478
per EA
DABIGATRAN ETEXILATE 75 MG CAP
Generic
67877047460•Ascend Laboratories, LLC
$0.8478
per EA